Safety of mRNA COVID-19 vaccines among persons 15- years and above in Ghana: A cohort event monitoring study
The study on mRNA COVID-19 vaccines in Ghana showed that the vaccines are tolerated well with no significant safety concerns. Reports of systemic and local events were consistent with those reported in the summary of product characteristics of the two vaccines. The study's outcome showed that there were no safety issues with mRNA COVID-19 vaccines in Ghana. The results of this study can be used as a crucial advocacy tool to address vaccine hesitancy as countries plan to routinize COVID-19 vaccines. Additionally, the active monitoring study serves as a model for such studies in low- to middle-income countries (LMICs) with weak pharmacovigilance systems during future pandemics.
Authors
- Comfort Ogar (ORCID: https://orcid.org/0000-0003-0448-7111)
- Kwame Amponsa-Achiano (ORCID: https://orcid.org/0000-0001-8145-970X)
- Abena Asamoa-Amoakohene (ORCID: https://orcid.org/0009-0003-2066-9940)
- Amani Wilfred (ORCID: https://orcid.org/0000-0002-4342-2006)
- George Tsey Sabblah (ORCID: https://orcid.org/0000-0003-1785-796X)
- Adela Ashie (ORCID: https://orcid.org/0009-0007-3228-7797)
- Seth Kwaku Seaneke
- Harriet Affran Bonful (ORCID: https://orcid.org/0000-0003-0069-3241)
- Richard Osei Buabeng (ORCID: https://orcid.org/0000-0002-9500-1502)
- Edwin Nkansah
- Eric Karikari-Boateng
- A. Hagos
- Delese Mimi Darko
- Naziru Tanko Mohamed
- Jeremiah Ewudzie-Sampson
- Alexander Mwinteru Derizie
- Adjabui D Neimatu
Institutions
- University of Ghana (GH)
- University of Groningen (NL)
- Children's Aid Society (US)
- Ministry of Food and Agriculture (GH)
- Ghana Health Service (GH)
Publication Details
- Journal
- Vaccine
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1016/j.vaccine.2024.126460
- Citations
- 3
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 1.58
Funders
- United States Agency for International Development
- United States Pharmacopeia